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INTRODUCTION
Various manifestations of allergic reaction caused by steroids 
have been reported. Among these, delayed reactions to topical-
ly applied corticosteroids are more common, whereas immedi-
ate reactions to systemic corticosteroids are rare. Immediate re-
actions of urticaria with angioedema, and even anaphylaxis, have 
been reported.
1 Allergic reactions can occur via intramuscular, 
intraarticular, intralesional, oral, inhalational, and intravenous 
routes. Reactions to oral corticosteroids have been document-
ed most commonly with prednisolone, but not with predni-
sone, betamethasone, triamcinolone, or methylprednisolone.
2 
The present case is, to our knowledge, the first case of acute 
generalized urticaria caused by oral methylprednisolone.
CASE REPORT
A 52-year old female had been diagnosed 13 years prior to the 
present admission with aspirin-exacerbated respiratory disease 
(AERD). The patient’s asthma had been partly controlled using 
anti-asthmatic medications including inhaled corticosteroids, a 
long-acting β2 agonist, and a leukotriene receptor antagonist. 
At the first visit, the patient was non-atopic with a PC20 metha-
choline level of 0.55 mg/mL. A lysine aspirin bronchoprovoca-
tion test showed a positive response at 300 mg/mL of lysine as-
pirin. Pansinusitis with nasal polyps was demonstrated by rhi-
noscopy.
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The patient was followed regularly with a maintenance medi-
cation regimen that included a combination of an inhaler and a 
leukotriene receptor antagonist. The patient had typically used 
a systematic steroid for several days for relief of asthma exacer-
bations; this regimen had been well-tolerated and proven ef-
fective in improving symptoms. 
More recently, the patient experienced worsening of dyspnea 
and wheezing, and was diagnosed with asthma exacerbation 
due to an upper respiratory infection; therefore, a low dose (8 
mg) of oral methylprednisolone was prescribed. Acute, whole 
body generalized urticaria developed after ingesting this medi-
cation. 
An oral provocation test was performed to confirm the casual 
relationship between the urticaria and cortisosteroids. No re-
sponses were observed following an oral provocation test to de-
flazacort, which is an alternative corticosteroid. However, 20 
minutes after taking oral methylprednisolone (4 mg), general-
ized urticaria developed (Figure). The diagnosis was acute gen-
eralized urticaria caused by oral methylprednisolone. 
The symptom-relieving therapy was changed from the use of 
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Although corticosteroids have immunosuppressive, anti-inflammatory, and anti-allergic effects, allergic reactions are rare. We report a case involv-
ing a 52-year-old-female with acute urticaria caused by oral methylprednisolone. The patient had experienced aspirin-exacerbated respiratory dis-
ease (AERD) for 13 years with frequent asthma exacerbations. Symptoms of asthma exacerbations improved with short-term treatments of system-
ic steroids, including methylprednisolone or deflazacort, which had been well tolerated. However, the current admission was prompted by the devel-
opment of acute generalized urticaria following the oral ingestion of methylprednisolone (8 mg) for relief of symptoms. An oral provocation test with 
4 mg oral methylprednisolone led to generalized urticaria 20 minutes later, confirming the causal association. This is the first report of acute urticaria 
caused by oral methylprednisolone in a patient with AERD.
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methylprednisolone to deflazacort. The patient has remained 
free from urticaria since that time.
To confirm the individual component of the steroid, we 
planned to perform allergic skin prick tests using pure methyl-
prednisolone, other steroids, and their additives, but failed, as 
she refused to stop taking antihistamines due to her persistent 
rhinitis symptoms.
DISCUSSION
Corticosteroid therapy involving a multitude of formulations 
is widely used in nearly all fields of medicine. A number of well-
documented cases of steroid hypersensitivity have been report-
ed. Delayed allergic reactions to topically applied corticosteroids 
are frequently observed (2.9%).
3 In contrast, immediate hyper-
sensitivity reactions are very rare (0.3%)
4 and present various 
manifestations from a simple transient skin rash or contact der-
matitis to respiratory distress and severe anaphylaxis.
1 Immedi-
ate hypersensitivity is generally found following intravenous 
administration and is commonly reported in asthmatic and re-
nal transplant patients.
5 A close association with AERD has been 
reported,
6,7 because patients with AERD tend to present with 
more severe asthma symptoms and are likely to be hospitalized 
and treated with intravenous corticosteroids. Repeated expo-
sure to intravenous corticosteroids increases the opportunity of 
sensitization to these drug antigens.
8 One study demonstrated 
the presence of specific immunoglobulin E (IgE) to methyl-
prednisolone in a patient with an anaphylactic reaction after 
infusion of methylprednisolone.
9 In the present study, the pa-
tient had suffered from AERD and had frequently been exposed 
to a high dose of systemic corticosteroids for many years. An 
oral provocation test revealed the development of generalized 
urticaria after exposure to a low dose of methylprednisolone. 
Although we did not perform allergy skin prick tests with indi-
vidual components and did not confirm the presence of serum 
specific IgE to methylprednisolone, the pathogenic mechanism 
may be an IgE-mediated reaction, as the patient demonstrated 
immediate onset urticaria after the low dose steroid applica-
tion. These findings suggest that even a low dose of oral meth-
ylprednisolone could induce an immediate allergic reaction in 
exposed patients.
Corticosteroid hypersensitivity may occur to the corticosteroid 
itself or to the preservatives, adjuvants, or stabilizers that are 
components of the preparation, making it difficult to quantify 
the risk. Succinate esters of hydrocortisone are the most fre-
quently responsible additive for type 1 allergic reactions to sys-
temic corticosteroids. The immunogenic role of succinate esters 
may involve their higher affinity to serum proteins, changing 
the steroid molecule from a hapten to a complete antigen.
10,11 
Anaphylaxis induced by the carboxymethylcellulose compo-
nent of an injectable steroid suspension has been reported.
12 
There are an increasing number of reports describing anaphy-
lactic reactions after an intra-articular injection of corticoste-
roids containing several mg of carboxymethycellulose, prednis-
olone acetate, and triamcinolone acetonide.
13 In the present 
study, a very low concentration of carboxymethycellulose was 
included in the methyprednisolone tablet and the patient’s 
clinical manifestation was immediate onset of generalized urti-
caria. Therefore, the possibility of additive-induced urticaria 
may be extremely low.
Diagnostic testing to systemic corticosteroids include skin 
patch, intradermal, and provocation tests. However, these tests 
suffer from low sensitivity and there is no consensus concern-
ing the most effective concentrations or vehicles to be used for 
skin testing. The most reliable method is a provocation test of 
the suspected systemic corticosteroid.
2 Possible cross-reactivi-
ties among hydrocortisone, methylprednisolone, and predni-
sone have been suggested.
14 Avoidance of hydrocortisone, 
Figure. Generalized urticaria that developed after 20 min of oral methylprednisolone exposure. (A) Photograph of the reaction on an ankle. (B) Photograph of the re-
action in the lower extremities.
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methylprednisolone, and prednisone in any formulation in pa-
tients displaying allergic reaction to systemic steroids has been 
recommended
1. Instead, betamethasone, deflazacort, or dexa-
methasone can be used as alternatives. However, the provoca-
tion test is the best way to identify glucocorticoids that are safe 
options for future therapy. Presently, the patient’s sensitivity 
was confirmed by an oral provocation test. No reaction to de-
flazacort was apparent, which was confirmed by the oral prov-
ocation test.
In conclusion, we report a case of oral methylprednisolone-
induced urticaria that developed in a patient with AERD. Con-
sidering the cross-reactivity between the corticosteroids, it is 
important to identify safe alternative steroid(s) by the provoca-
tion test. 
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